SCHEMBL18554579

SCHEMBL18554579

CCOC(=O)CCc1nc2ccc(C(C(=O)OC)(c3ccc(Cl)cc3)c3ccc(Cl)cc3)cc2n1C1CCN(C(=O)O)C(C(C)(C)C)C1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 4/20 0.35
▸ NPSR1 Q6W5P4 3/20 0.35
▸ ALDH1A1 P00352 2/20 0.32
▸ HDAC1 Q13547 2/20 0.32
▸ KDM4E B2RXH2 2/20 0.32
▸ LMNA P02545 1/20 0.32
▸ MAPK1 P28482 1/20 0.32
▸ HSD17B10 Q99714 1/20 0.32
▸ CNR1 P21554 1/20 0.32
▸ CNR2 P34972 1/20 0.32
▸ FPR2 P25090 1/20 0.32
▸ IDO1 P14902 1/20 0.32
▸ KCNH2 Q12809 1/20 0.32
▸ MET P08581 1/20 0.31
▸ ALK Q9UM73 1/20 0.31
▸ OPRM1 P35372 1/20 0.31
▸ OPRK1 P41145 1/20 0.31
▸ OGFRL1 Q5TC84 1/20 0.31
▸ HRH4 Q9H3N8 1/20 0.31
▸ GAA P10253 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18547271 0.84 ALDH1A1 (0.41) NPSR1ALDH1A1KDM4ELMNAHSD17B10
SCHEMBL18547309 0.70 CNR1 (0.42) CNR1CNR2FPR2
SCHEMBL18547013 0.69 CNR1 (0.42) NPSR1ALDH1A1KDM4ELMNAHSD17B10
SCHEMBL18547268 0.68 CNR1 (0.44) MAPTNPSR1ALDH1A1LMNAHSD17B10
SCHEMBL18547342 0.65 CNR1 (0.40) NPSR1LMNAHSD17B10CNR1OPRM1
SCHEMBL18547002 0.65 P2RX3 (0.45) MAPTKDM4ELMNAHSD17B10CNR1
SCHEMBL18547281 0.65 ALK (0.41) MAPTALDH1A1KDM4ELMNAMET
SCHEMBL18547274 0.64 OPRM1 (0.41) LMNACNR1CNR2OPRM1OPRK1
SCHEMBL20679656 0.64 OPRM1 (0.41) LMNACNR1CNR2OPRM1OPRK1
SCHEMBL18547273 0.64 OPRM1 (0.41) LMNACNR1CNR2OPRM1OPRK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2017035114-A1 BENZIMIDAZOLE DERIVATIVES USEFUL AS CB-1 INVERSE AGONISTS JANSSEN PHARMACEUTICA NV (BE) 2017-03-02 — — WO disclosed
Send feedback